These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 7543053
1. Alterations of the cytoskeletal organization in tumor cell lines by a cardiotonic drug, vesnarinone, through protein tyrosine phosphorylation. Yoshinaka Y, Katoh I, Kyushiki H, Sakamoto Y. Exp Cell Res; 1995 Jul; 219(1):21-8. PubMed ID: 7543053 [Abstract] [Full Text] [Related]
2. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor. Brunton VG, Carlin S, Workman P. Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899 [Abstract] [Full Text] [Related]
4. Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells. Agbotounou WK, Levitzki A, Jacquemin-Sablon A, Pierre J. Mol Pharmacol; 1994 May; 45(5):922-31. PubMed ID: 7514714 [Abstract] [Full Text] [Related]
5. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells. Zhong H, Minneman KP. Biochem J; 1999 Dec 15; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878 [Abstract] [Full Text] [Related]
7. Modulation of the cytotoxic activity of tumor necrosis factor by protein tyrosine kinase and protein tyrosine phosphatase inhibitors. Mishra S, Mathur R, Hamburger AW. Lymphokine Cytokine Res; 1994 Apr 15; 13(2):77-83. PubMed ID: 8061118 [Abstract] [Full Text] [Related]
8. Application of two-dimensional gel analysis to identification and characterization of tyrosine phosphorylated substrates for growth factor receptors. Hansen K, Møller JV. Electrophoresis; 1993 Apr 15; 14(1-2):112-26. PubMed ID: 7681772 [Abstract] [Full Text] [Related]
9. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK, Chen PB. Oncogene; 1997 Sep 04; 15(10):1191-7. PubMed ID: 9294612 [Abstract] [Full Text] [Related]
10. Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors. Han Y, Caday CG, Nanda A, Cavenee WK, Huang HJ. Cancer Res; 1996 Sep 01; 56(17):3859-61. PubMed ID: 8752145 [Abstract] [Full Text] [Related]
11. Tyrosine kinase activity is necessary for growth factor-stimulated rabbit type II pneumocyte proliferation. Chess PR, Ryan RM, Finkelstein JN. Pediatr Res; 1994 Oct 01; 36(4):481-6. PubMed ID: 7529394 [Abstract] [Full Text] [Related]
12. Actin polymerization localizes to the activated epidermal growth factor receptor in the plasma membrane, independent of the cytosolic free calcium transient. Rijken PJ, Post SM, Hage WJ, van Bergen en Henegouwen PM, Verkleij AJ, Boonstra J. Exp Cell Res; 1995 May 01; 218(1):223-32. PubMed ID: 7737361 [Abstract] [Full Text] [Related]
13. Tyrosine phosphorylation at the membrane-microfilament interface: a p185neu-associated signal transduction particle containing Src, Abl and phosphorylated p58, a membrane- and microfilament-associated retroviral gag-like protein. Juang SH, Carvajal ME, Whitney M, Liu Y, Carraway CA. Oncogene; 1996 Mar 07; 12(5):1033-42. PubMed ID: 8649794 [Abstract] [Full Text] [Related]
14. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells. Sion-Vardy N, Vardy D, Rodeck U, Kari C, Levin RM, Malkowicz SB. J Surg Res; 1995 Dec 07; 59(6):675-80. PubMed ID: 8538164 [Abstract] [Full Text] [Related]
15. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation. Lipson KE, Pang L, Huber LJ, Chen H, Tsai JM, Hirth P, Gazit A, Levitzki A, McMahon G. J Pharmacol Exp Ther; 1998 May 07; 285(2):844-52. PubMed ID: 9580635 [Abstract] [Full Text] [Related]
16. The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice. Yoneda T, Lyall RM, Alsina MM, Persons PE, Spada AP, Levitzki A, Zilberstein A, Mundy GR. Cancer Res; 1991 Aug 15; 51(16):4430-5. PubMed ID: 1651159 [Abstract] [Full Text] [Related]
17. Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells. Lei W, Mayotte JE, Levitt ML. Anticancer Res; 1999 Aug 15; 19(1A):221-8. PubMed ID: 10226546 [Abstract] [Full Text] [Related]
18. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases. Ahmad F, Goldstein BJ. J Cell Biochem; 1997 Jan 15; 64(1):117-27. PubMed ID: 9015760 [Abstract] [Full Text] [Related]
19. Decrease in coupling of Gs in v-src-transformed NIH-3T3 fibroblasts: possible involvement of tyrosine phosphorylation of Gs by pp60v-src. Akiho H, Tokumitsu Y, Noda M, Nomura Y. Arch Biochem Biophys; 1993 Jul 15; 304(1):235-41. PubMed ID: 7686735 [Abstract] [Full Text] [Related]
20. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners. Showalter HD, Sercel AD, Leja BM, Wolfangel CD, Ambroso LA, Elliott WL, Fry DW, Kraker AJ, Howard CT, Lu GH, Moore CW, Nelson JM, Roberts BJ, Vincent PW, Denny WA, Thompson AM. J Med Chem; 1997 Feb 14; 40(4):413-26. PubMed ID: 9046331 [Abstract] [Full Text] [Related] Page: [Next] [New Search]